# Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

> **NCT00003615** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 77 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** denileukin diftitox

## Key facts

- **NCT ID:** NCT00003615
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05-20
- **Primary completion:** 2006-08
- **Final completion:** —
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003615, "Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*